Poland - Pharmaceutical products

Description

The subject of the order is successive supply of drugs used in opioid substitution therapy, vaccines for children and adults and human immunoglobulin for the needs of Wroclaw Health Care Center SPZOZ. A detailed description of the subject matter of the contract is contained in part II of the SWZ - OPZ. The Ordering Party allows for partial bids for individual parts from No. 1 to No. 29 described in the OPZ. Bids in the proceedings may be submitted for: one, several or all parts.
The subject of the order is the supply of preparations: Methadone concentrate for oral solution 10 mg/ml, 1000 ml - 1000 packages Levomethadone hydrochloride oral solution 5 mg/ml, 500 ml - 600 packages Buprenorphine 2 mg sublingual tablets, number of tablets per package - 28 pcs. - 800 packages Buprenorphine 8 mg sublingual tablets, number of tablets per package - 28 pcs. - 1000 packages The subject of the order is the supply of inactivated hepatitis A vaccine for adults, inactivated, adsorbed - 130 packages Supply of a preparation containing not less than 5 IU of diphtheria toxoid and not less than 40 IU.IU of tetanus toxoid for adolescents and adults, volume 0.5 ml in an ampoule - quantity of 10 packages The subject of the order is the supply of a preparation containing diphtheria toxoid, cell-free pertussis vaccine and tetanus toxoid for children from 4 years of age. and adults, volume 0.5 ml in a pre-filled syringe - quantity 30 packages The subject of the order is the supply of a preparation containing diphtheria toxoid, cell-free vaccine against pertussis, inactivated vaccine against poliomyelitis and tetanus toxoid for children from 4 years of age. and adults, volume 0.5 ml in a pre-filled syringe - quantity of 35 packages The subject of the order is the supply of a preparation containing diphtheria toxoid, tetanus toxoid and poliomyelitis vaccine - quantity of packages 5 The subject of the order is the supply of vaccine against tick-borne encephalitis containing the whole virus for persons from 16 years of age, volume 0.5 ml in a pre-filled syringe - number of packages 40 The subject of the order is the supply of vaccine against tick-borne encephalitis containing the whole virus for children from 1 to 15 years of age, volume 0.25 ml in a pre-filled syringe- number of 80 packages The subject of the order is the supply of a preparation containing diphtheria toxoid, vaccine against H. influenzae type B, recombinant vaccine against hepatitis B, cell-free vaccine against pertussis (3 components), inactivated vaccine against poliomyelitis and tetanus toxoid, 1 vial with powder + 1 ampoule syringe volume 0.5 ml with contents + 2 needles - quantity 250 packages The subject of the order is the supply of a preparation containing diphtheria toxoid, vaccine against H. influenzae type B, cell-free vaccine against pertussis (2 components), inactivated vaccine against poliomyelitis and tetanus toxoid for children from 2 m of age - the amount of 250 packages. amount of 60 packages The subject of the order is the supply of a preparation containing diphtheria toxoid, vaccine against H. influenzae type B, recombinant vaccine against hepatitis B, cell-free vaccine against pertussis (2 components), inactivated vaccine against poliomyelitis and tetanus toxoid - amount of 500 packages The subject of the order is the supply of meningococcal quadrivalent vaccine (A+C+W135+Y) for children from 12 m. of age, containing 1 vial with powder and 1 ampoule syringe with solution - quantity of 400 packages The subject of the order is the supply of pneumococcal polysaccharide conjugated adsorbed vaccine for infants from 6 weeks of age, children, adolescents and adults - number of packages350 The subject of the order is the delivery of polysaccharide pneumococcal vaccine for children from 2 years of age and adults - number of packages 30 The subject of the order is the delivery of live, attenuated vaccine against yellow fever - number of packages 50 The subject of the order is the delivery of meningococcal vaccine gr. B for infants from 2 m.o, children and adults- number of packages 500 The subject of the order is the supply of inactivated vaccine against poliomyelitis, volume 0.5 ml in a pre-filled syringe- number of packages 10 The subject of the order is the supply of recombinant vaccine against hepatitis B for adults- number of packages 160 The subject of the order is the supply of polysaccharide vaccine against typhoid fever for children from the age of 2. and adults, volume 0.5 ml in a pre-filled syringe- number of packages 150 The subject of the order is the supply of inactivated vaccine against hepatitis A combined with recombinant vaccine against hepatitis B for adolescents from 16 years of age. and adults, volume 1 ml in an ampoule-syringe- number of packages 35 The subject of the order is the supply of smallpox vaccine for children from 9 m. and adults, volume 0.5 ml, vial with powder and ampoule-syringe with solvent.- number of packages. number of packages 50 The subject of the order is the supply of rabies vaccine for children and adults for pre- and post-exposure immunization- number of packages 100 The subject of the order is the supply of cholera vaccine- number of packages 6 The subject of the order is the supply of human anti-rh0(d) immunoglobulin, solution for injection; 300 µg (1500 IU.)/2 ml; 1 ampoule syringe 2 ml - number of packages 130 The subject of the order is the supply of vaccine against Japanese encephalitis - number of packages 10 The subject of the order is the supply of 9-valent vaccine against human papillomavirus (HPV)- number of packages 250 The subject of the order is the supply of tetanus vaccine, adsorbed - number of packages 50 The subject of the order is the supply of 4-valent vaccine against influenza (cleaved virus), inactivated, in accordance with the recommendations of the World Health Organization - WHO (for the Northern Hemisphere) and with the recommendations of the European Union for the season 2023/2024 - number of packages 200 The subject of the order is the supply of 4-valent influenza vaccine (surface antigen), inactivated, in accordance with the recommendations of the World Health Organization - WHO (for the Northern Hemisphere) and with the recommendations of the European Union for the season 2023/2024 - number of packages 100

Opportunity closing date

09 March 2023

Value of contract

to be confirmed